Company
United StatesPublic company, NASDAQ: GRFSGrifols (NASDAQ: GRFS), Fort Walton Beach, FL – FDA Inspections
Inspection records and compliance data for Grifols in Fort Walton Beach, Florida. 2 FDA inspections on record, last inspected June 02, 2023. Publicly traded as NASDAQ: GRFS.
Company Profile
This profile covers Grifols based in Fort Walton Beach, Florida, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected August 8, 2018. Last inspected June 2, 2023.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 2, 2023 | NAI | Biologics · Blood and Blood Products | 1209565 |
| August 8, 2018 | Not classified | Biologics | 1066085 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Grifols
Stock ticker
GRFS
Exchange
NASDAQ
Share price
$8.51
Market cap
$5.8B
Price as of
November 6, 2026
FEI Number
3013848392
Address
234a Eglin Pkwy Ne, Fort Walton Beach, Florida 32547, United States
Country
United States
ID: fa0b89a9-1806-46d1-a214-9bdc432f71dc